Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for InterCure Ltd. as of 31 December 2024 is 238.84 MM.
- The operating income for InterCure Ltd. as of 31 December 2024 is -87.89 MM.
- The net income for InterCure Ltd. as of 31 December 2024 is -67.80 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2024-12-31 | 238.84 | -87.89 | -67.80 |
2024-09-30 | 255.76 | -44.62 | -66.71 |
2024-06-30 | 272.67 | -2.97 | -65.62 |
2024-03-31 | 312.24 | -2.29 | -61.46 |
2023-12-31 | 355.55 | 0.10 | -61.96 |
2023-09-30 | 387.69 | -8.10 | -19.88 |
2023-06-30 | 414.79 | 14.60 | 20.90 |
2023-03-31 | 407.63 | 26.76 | 31.66 |
2022-12-31 | 388.68 | 40.23 | 44.82 |
2022-09-30 | 362.78 | 65.88 | 33.20 |
2022-06-30 | 323.90 | 54.18 | 24.30 |
2022-03-31 | 273.86 | 44.90 | 14.85 |
2021-12-31 | 219.68 | 30.05 | 4.69 |
2021-09-30 | 167.07 | 23.61 | 16.98 |
2021-06-30 | 127.87 | 21.99 | 20.36 |
2021-03-31 | 93.83 | 12.38 | 13.19 |
2020-12-31 | 65.03 | -1.21 | -37.23 |
2020-09-30 | 39.77 | -12.04 | -63.09 |
2020-06-30 |
Income Statement: EPS
- The earnings per share basic for InterCure Ltd. as of 31 December 2024 is -1.48.
- The earnings per share diluted for InterCure Ltd. as of 31 December 2024 is -1.48.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2024-12-31 | -1.48 | -1.48 |
2024-09-30 | -1.45 | -1.45 |
2024-06-30 | -1.42 | -1.42 |
2024-03-31 | -1.31 | -1.31 |
2023-12-31 | -1.36 | -1.36 |
2023-09-30 | -0.41 | -0.41 |
2023-06-30 | 0.46 | 0.46 |
2023-03-31 | 0.67 | 0.67 |
2022-12-31 | 0.99 | 0.99 |
2022-09-30 | 0.89 | 0.88 |
2022-06-30 | 0.58 | 0.57 |
2022-03-31 | 0.35 | 0.33 |
2021-12-31 | 0.12 | 0.11 |
2021-09-30 | 0.43 | 0.39 |
2021-06-30 | 0.88 | 0.77 |
2021-03-31 | 0.53 | 0.52 |
2020-12-31 | -1.47 | -1.47 |
2020-09-30 | -2.55 | -2.54 |
2020-06-30 | -2.63 | -2.61 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for InterCure Ltd. as of 31 December 2024 is -66.93 MM.
- The cash from investing activities for InterCure Ltd. as of 31 December 2024 is 17.69 MM.
- The cash from financing activities for InterCure Ltd. as of 31 December 2024 is 26.45 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2024-12-31 | -66.93 | 17.69 | 26.45 |
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | -53.63 | 4.77 | -82.89 |
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | -4.34 | -147.18 | 43.33 |
2022-12-31 | 51.27 | -142.50 | 120.45 |
2022-09-30 | 17.01 | -105.09 | 90.59 |
2022-06-30 | 24.39 | -89.09 | 81.98 |
2022-03-31 | 25.50 | -69.13 | 214.81 |
2021-12-31 | 30.14 | -65.21 | 197.94 |
2021-09-30 | 31.58 | -46.46 | 176.72 |
2021-06-30 | 25.41 | -19.67 | 185.49 |
2021-03-31 | 19.41 | -22.45 | 26.36 |
2020-12-31 | 7.90 | -22.76 | 25.20 |
2020-09-30 | -2.97 | -22.20 | 37.78 |
2020-06-30 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 |
Management Effectiveness
- The roa for InterCure Ltd. as of 31 December 2024 is -0.08.
- The roe for InterCure Ltd. as of 31 December 2024 is -0.15.
- The roic for InterCure Ltd. as of 31 December 2024 is -0.11.
- The croic for InterCure Ltd. as of 31 December 2024 is 0.00.
- The ocroic for InterCure Ltd. as of 31 December 2024 is 0.00.
Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
2024-12-31 | -0.08 | -0.15 | -0.11 | 0.00 | 0.00 |
2024-09-30 | -0.08 | -0.15 | -0.11 | -0.21 | -0.09 |
2024-06-30 | -0.07 | -0.12 | -0.09 | -0.20 | -0.08 |
2024-03-31 | 0.02 | 0.04 | |||
2023-12-31 | 0.02 | 0.04 | -0.03 | -0.15 | -0.01 |
2023-09-30 | 0.03 | 0.04 | 0.03 | 0.00 | 0.00 |
2023-06-30 | 0.04 | 0.04 | 0.03 | -0.14 | -0.01 |
2023-03-31 | 0.04 | 0.07 | 0.04 | -0.14 | -0.01 |
2022-12-31 | 0.05 | 0.07 | 0.05 | 0.01 | 0.02 |
2022-09-30 | 0.04 | 0.07 | 0.05 | 0.01 | 0.02 |
2022-06-30 | 0.03 | 0.05 | 0.04 | 0.03 | 0.03 |
2022-03-31 | 0.05 | 0.05 | 0.03 | 0.29 | 0.03 |
2021-12-31 | 0.05 | 0.06 | 0.01 | 0.29 | 0.05 |
2021-09-30 | 0.05 | 0.06 | 0.03 | 0.32 | 0.05 |
2021-06-30 | 0.08 | 0.09 | 0.04 | 0.40 | 0.05 |
2021-03-31 | 0.05 | 0.06 | 0.04 | 0.08 | 0.06 |
2020-12-31 | -0.13 | -0.15 | -0.12 | 0.03 | 0.03 |
2020-09-30 | -0.22 | -0.23 | -0.20 | 0.04 | -0.01 |
2020-06-30 | -0.27 | -0.29 | -0.37 | -0.20 | -0.07 |
Gross Margins
- The gross margin for InterCure Ltd. as of 31 December 2024 is 0.29.
- The net margin for InterCure Ltd. as of 31 December 2024 is -0.24.
- The operating margin for InterCure Ltd. as of 31 December 2024 is -0.01.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
2024-12-31 | 0.29 | -0.24 | -0.01 |
2024-09-30 | 0.29 | -0.24 | -0.01 |
2024-06-30 | 0.31 | -0.17 | -0.00 |
2024-03-31 | 0.38 | 0.05 | 0.04 |
2023-12-31 | 0.38 | 0.05 | 0.04 |
2023-09-30 | 0.38 | 0.05 | 0.04 |
2023-06-30 | 0.42 | 0.05 | 0.04 |
2023-03-31 | 0.46 | 0.08 | 0.07 |
2022-12-31 | 0.46 | 0.09 | 0.18 |
2022-09-30 | 0.47 | 0.09 | 0.18 |
2022-06-30 | 0.46 | 0.08 | 0.17 |
2022-03-31 | 0.46 | 0.05 | 0.16 |
2021-12-31 | 0.46 | 0.02 | 0.14 |
2021-09-30 | 0.49 | 0.10 | 0.14 |
2021-06-30 | 0.49 | 0.16 | 0.17 |
2021-03-31 | 0.50 | 0.14 | 0.13 |
2020-12-31 | 0.52 | -0.57 | -0.02 |
2020-09-30 | 0.52 | -1.59 | -0.23 |
2020-06-30 | 0.51 | -4.04 | -1.33 |
Identifiers and Descriptors
Central Index Key (CIK) | 1610950 |
Industry Groups
SIC 8731 - Commercial Physical and Biological Research |